SUMMARY:

• The FDA has many puzzled as to why they approve some drugs with questionable data and ask for more data on other drugs.
• The FDA approves drugs on the potential to save a life, the cost of the drugs is never considered in the process.
• The FDA has been under criticism, but an internal investigation will focus on approval processes, not “why” a drug was approved.
• Our healthcare system cannot continue to support marginally effective drugs. We need to learn to say NO.
• Drug companies know how to play the system.